advertisement
App Information
Version
Update
Mar 06, 2024
Developer
Category
Google Play ID
Installs
1,000+
App Names
App Description
Carcinoembryonic Score is the first application dedicated to the prevention and management of febrile neutropenia in patients undergoing cancer chemotherapy. More than 300 protocols, classified by tumor location, are subject to a summary description taking the actual rate of neutropenia Febrile, the risk of neutropenia associated Feverish and the recommendations of the EORTC regarding prophylactic G-CSF. A calculation tool for assessing patient risk factors and score MASCC complement each plug.
To further enrich the application, we are launching this year a fourth version of CancéroScore that incorporates updated based chemotherapies and immunotherapies (CIRS-G scores, IPSS and ISS-R).
Finally, the big news this year is the creation of a new "immunohistochemistry". This new feature will allow you to better understand immunohistochemical analysis transcribed in the minutes pathological addressed to you.
Designed for everyday use, this application is simple and intuitive for all health professionals working in Oncology and Hematology.
Access to this application is for medical professionals.
To further enrich the application, we are launching this year a fourth version of CancéroScore that incorporates updated based chemotherapies and immunotherapies (CIRS-G scores, IPSS and ISS-R).
Finally, the big news this year is the creation of a new "immunohistochemistry". This new feature will allow you to better understand immunohistochemical analysis transcribed in the minutes pathological addressed to you.
Designed for everyday use, this application is simple and intuitive for all health professionals working in Oncology and Hematology.
Access to this application is for medical professionals.
Read more
